Metastatic Prostate Cancer
Metastatic prostate cancer is a stage of prostate cancer where the disease has spread from the prostate gland to other parts of the body, often leading to more severe symptoms and complications.
Prostate Cancer: Apalutamide with Surgery
We are studying if adding apalutamide to standard hormone therapy helps men with high-risk prostate cancer after surgery. The goal is to see if this combination improves cancer control compared to hormone therapy alone.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have prostate cancer that has been confirmed by a doctor?
- Are you currently taking any medications that could interfere with the study, like certain hormone treatments?
- Have you had any major heart problems in the last year, like a heart attack or severe angina?
- Do you have any gastrointestinal conditions that affect how your body absorbs medications?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universita Humanitas
Biomedical Sciences
Basiglio, Italy
IRCCS Ospedale Policlinico San Martino
Specialized Surgery
Genoa, Italy
Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali
Urology
Latina, Italy
Sponsor: Universita' Degli Studi Di Torino
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.